What is Biofil Chemicals & Pharmaceuticals share price return in the past 10 years?

Biofil Chemicals & Pharmaceuticals Ltd share price has appreciated 40.4% annually (CAGR) over the past ten years.

What is the P/E ratio of Biofil Chemicals & Pharmaceuticals?

The latest standalone P/E ratio of Biofil Chemicals & Pharmaceuticals as of 21-Nov-2024 is 153.84.

What is the P/B ratio of Biofil Chemicals & Pharmaceuticals?

The latest standalone P/B ratio of Biofil Chemicals & Pharmaceuticals as of 21-Nov-2024 is 5.30.

What is the 52-week high and low of Biofil Chemicals & Pharmaceuticals?

The 52-week high of Biofil Chemicals & Pharmaceuticals is Rs. 92.00 and the 52-week low is Rs. 42.61.

Biofil Chemicals & Pharmaceuticals Ltd - Stock Valuation and Financial Performance

Name: Biofil Chemicals & Pharmaceuticals
Brand: Biofil Chemicals & Pharmaceuticals

BSE: 524396 | NSE: BIOFILCHEM | Pharmaceuticals & Drugs | Small Cap

Place order

Biofil Chem & Pharma Share Price

₹59.16 -0.68 -1.14%
as on 21-Nov'24 16:59

DeciZen - make an informed investing decision on Biofil Chem & Pharma

Based on:

Data

M-Cap below 100cr DeciZen not available

Biofil Chemicals & Pharmaceuticals stock performance -

PE Chart Key Ratios

P/E Ratio (SA):

153.84

Market Cap:

97.4 Cr.

52-wk low:

42.6

52-wk high:

Is Biofil Chemicals & Pharmaceuticals Ltd an attractive stock to invest in?

1. Is Biofil Chemicals & Pharmaceuticals Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Biofil Chemicals & Pharmaceuticals Ltd is a below average quality company.

2. Is Biofil Chemicals & Pharmaceuticals Ltd undervalued or overvalued?

The key valuation ratios of Biofil Chemicals & Pharmaceuticals Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

3. Is Biofil Chemicals & Pharmaceuticals Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Biofil Chemicals & Pharmaceuticals Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Biofil Chem & Pharma:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
ROCE % ⓘ	13%	14%	21.9%	5.1%	5.1%	10.1%	12.2%	6.2%	4.8%	5%	-
Value Creation Index ⓘ	-0.1	0	0.6	-0.6	-0.6	-0.3	-0.1	-0.6	-0.7	-0.7	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	5.9	13.2	13.5	12.4	23.1	29.7	35.8	22.4	30	40	46
Sales YoY Gr.	-	124.7%	2.1%	-8.1%	87.1%	28.4%	20.4%	-37.4%	34.2%	33.3%	-
Adj EPS ⓘ	0.4	0.5	1.1	0.3	0.3	0.7	0.8	0.4	0.3	0.4	0.4
YoY Gr.	-	33.3%	129.2%	-73.6%	3.5%	146.7%	2.7%	-43.4%	-20.9%	29.4%	-
BVPS (₹) ⓘ	2.9	4.4	7.8	8.1	8.4	9.2	9.9	10.4	10.6	11.2	11.3
Adj Net Profit ⓘ	0.6	0.8	1.8	0.5	0.5	1.2	1.2	0.7	0.6	0.7	1
Cash Flow from Ops. ⓘ	0	0.1	0.7	0.5	1.3	0.9	1.1	-0.2	-0.1	2.4	-
Debt/CF from Ops. ⓘ	325.6	10	2	3.4	1.3	1.3	0.4	-2.1	-4.7	0.2	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	23.8%	11.6%	3.9%	33.3%
Adj EPS ⓘ	2.3%	8%	-16.7%	29.4%
BVPSⓘ	16.4%	5.9%	4.1%	5.3%
Share Price	40.4%	64.8%	-0.6%	22.2%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
Return on Equity % ⓘ	7.2	8.1	15.2	3.6	3.6	8.5	8	4.2	3.3	4	3.5
Op. Profit Mgn % ⓘ	12.5	6.6	19.5	7.6	4.4	6.1	4.5	6	3.9	2	1.5
Net Profit Mgn % ⓘ	10	5.9	13.3	3.8	2.1	4.1	3.5	3.1	1.9	1.8	1.4
Debt to Equity ⓘ	0.6	0.2	0.1	0.1	0.1	0.1	0	0	0	0	-
Working Cap Days ⓘ	306	271	371	397	223	282	281	262	192	267	100
Cash Conv. Cycle ⓘ	51	43	31	139	68	51	65	74	101	76	27

Recent Performance Summary

Sales growth is good in last 4 quarters at 264.87%

Return on Equity has declined versus last 3 years average to 3.50%

Sales growth has been subdued in last 3 years 3.85%

Net Profit has been subdued in last 3 years -16.65%

Latest Financials - Biofil Chemicals & Pharmaceuticals Ltd.

	Standalone	Consolidated
TTM EPS (₹)	0.4	-
TTM Sales (₹ Cr.)	46.1	-
BVPS (₹.) ⓘ	11.3	-
Reserves (₹ Cr.) ⓘ	2	-
P/BV ⓘ	5.30	-
PE ⓘ	153.84	-

From the Market
52 Week Low / High (₹)	42.61 / 92.00
All Time Low / High (₹)	0.30 / 352.45
Market Cap (₹ Cr.)	97.4
Equity (₹ Cr.)	16.3
Face Value (₹)	10
Industry PE ⓘ	43

Management X-Ray of Biofil Chem & Pharma:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Biofil Chem & Pharma

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Biofil Chem & Pharma

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Sales	5.86	13.17	13.45	12.36	23.13	29.69	35.75	22.38	30.04	40.04
Operating Expenses ⓘ	5.13	12.30	10.83	11.42	22.11	27.87	34.15	21.05	28.87	39.22
Manufacturing Costs	0.54	0.85	0.91	0.48	0.58	1.04	0.59	0.45	0.49	0.69
Material Costs	3.85	10.52	8.51	9.77	19.99	25.31	32.43	19.46	27.42	37.51
Employee Cost	0.50	0.48	0.53	0.73	0.89	0.86	0.75	0.79	0.45	0.50
Other Costs ⓘ	0.24	0.44	0.88	0.45	0.64	0.65	0.38	0.35	0.51	0.53
Operating Profit ⓘ	0.73	0.87	2.62	0.94	1.02	1.82	1.60	1.33	1.17	0.82
Operating Profit Margin (%)	12.5%	6.6%	19.5%	7.6%	4.4%	6.1%	4.5%	6.0%	3.9%	2.0%
Other Income ⓘ	0.46	0.53	0.14	0.10	0.10	0.17	0.80	0.15	0.10	0.49
Interest ⓘ	0.21	0.15	0.16	0.15	0.16	0.12	0.07	0.04	0.04	0.04
Depreciation ⓘ	0.25	0.26	0.28	0.30	0.37	0.41	0.41	0.43	0.43	0.40
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Profit Before Tax ⓘ	0.74	0.98	2.31	0.59	0.60	1.46	1.92	1.01	0.79	0.87
Tax ⓘ	0.15	0.20	0.52	0.12	0.12	0.26	0.68	0.32	0.23	0.16
Profit After Tax	0.59	0.78	1.79	0.47	0.48	1.21	1.24	0.70	0.56	0.71
PAT Margin (%)	10.0%	5.9%	13.3%	3.8%	2.1%	4.1%	3.5%	3.1%	1.9%	1.8%
Adjusted EPS (₹)	0.4	0.5	1.1	0.3	0.3	0.7	0.8	0.4	0.3	0.4
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Equity and Liabilities
Shareholders Fund	8.41	10.91	12.70	13.17	13.65	14.88	16.13	16.84	17.30	18.20
Share Capital ⓘ	16.27	16.27	16.27	16.27	16.27	16.27	16.27	16.27	16.27	16.27
Reserves ⓘ	-7.86	-5.37	-3.58	-3.11	-2.62	-1.39	-0.14	0.56	1.03	1.93
Minority Interest	0	0	0	0	0	0	0	0	0	0
Debt	2.98	1.37	1.43	1.56	1.64	1.19	0.43	0.46	0.52	0.44
Long Term Debt	0	0	0	0	0	0	0	0	0	0
Short Term Debt	2.98	1.37	1.43	1.56	1.64	1.19	0.43	0.46	0.52	0.44
Trade Payables	2.11	11.59	7.10	9.14	8.58	25.92	15.85	0.60	12.65	27.55
Others Liabilities ⓘ	0.25	0.26	0.62	0.29	0.34	0.37	0.83	0.83	0.93	0.89
Total Liabilities ⓘ	13.76	24.13	21.84	24.15	24.21	42.36	33.24	18.73	31.41	47.08
Fixed Assets
Gross Block	10.85	11.04	9.45	9.83	11.24	11.45	11.55	11.62	11.63	11.65
Accumulated Depreciation	1.79	2.06	0.29	0.58	0.95	1.36	1.77	2.20	2.63	3.03
Net Fixed Assetsⓘ	9.06	8.98	9.16	9.25	10.29	10.09	9.78	9.42	9	8.62
CWIP ⓘ	0	0	0	0	0	0	0	0	0	0
Investmentsⓘ	0	0	0	0	0	0	0	0	0	0
Inventories	0.17	0.10	0.17	1.02	1.19	1.69	4.34	1.29	1.21	2.55
Trade Receivables	3.65	13.98	11.46	12.98	12.03	29.71	17.22	7.17	20.50	33.03
Cash Equivalents	0.13	0.18	0.31	0.37	0.14	0.26	0.44	0.14	0.04	2.28
Others Assetsⓘ	0.75	0.89	0.74	0.53	0.57	0.62	1.46	0.70	0.65	0.60
Total Assets ⓘ	13.76	24.13	21.84	24.15	24.21	42.36	33.24	18.73	31.41	47.08

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Cash Flow From Operating Activity ⓘ	0.01	0.14	0.71	0.46	1.26	0.89	1.11	-0.22	-0.11	2.39
PBT ⓘ	0.74	0.98	2.31	0.59	0.60	1.46	1.92	1.01	0.79	0.87
Adjustment ⓘ	0.46	0.42	0.45	0.45	0.53	0.56	0.48	0.48	0.38	0.63
Changes in Working Capital ⓘ	-0.84	-0.96	-1.84	-0.07	0.25	-0.87	-0.62	-1.4	-1.05	1.05
Tax Paid ⓘ	-0.13	-0.15	-0.20	-0.50	-0.11	-0.25	-0.68	-0.32	-0.23	-0.16
Cash Flow From Investing Activity ⓘ	-0.17	-0.19	-0.48	-0.38	-1.41	-0.21	-0.10	-0.07	-0.01	-0.02
Capex	-0.17	-0.19	-0.48	-0.38	-1.41	-0.21	-0.10	-0.07	-0.01	-0.02
Net Investments	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0	0	0	0	0	0	0	0	0	0
Cash Flow From Financing Activityⓘ	0.11	0.10	-0.11	-0.02	-0.08	-0.57	-0.83	-0.01	0.02	-0.12
Net Proceeds from Shares ⓘ	0	1.71	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0.11	0	0	0	0	0	0	0	0	0
Interest Paid ⓘ	0	0	-0.16	-0.15	-0.16	-0.12	-0.07	-0.04	-0.04	-0.04
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0	-1.61	0.06	0.13	0.08	-0.45	-0.76	0.03	0.06	-0.08
Net Cash Flow ⓘ	-0.05	0.05	0.13	0.06	-0.24	0.12	0.18	-0.30	-0.11	2.25

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Ratios
ROE (%)	13.47	13.28	18.09	3.64	3.6	8.46	8.01	4.24	3.28	4
ROCE (%)	12.97	14.04	21.86	5.13	5.06	10.12	12.18	6.23	4.76	4.97
Asset Turnover Ratio	0.41	0.7	0.59	0.54	0.96	0.89	0.95	0.86	1.2	1.02
PAT to CFO Conversion(x)	0.02	0.18	0.4	0.98	2.63	0.74	0.9	-0.31	-0.2	3.37
Working Capital Days
Receivable Days	241	244	345	361	197	257	240	199	168	244
Inventory Days	14	4	4	18	17	18	31	46	15	17
Payable Days	272	238	401	303	162	249	235	154	88	196

Biofil Chemicals & Pharmaceuticals Ltd Stock News

Biofil Chemicals & Pharmaceuticals Ltd FAQs

What is the share price of Biofil Chem & Pharma?

Company share prices are keep on changing according to the market conditions. The closing price of Biofil Chem & Pharma on 21-Nov-2024 16:59 is ₹59.16.

What is the market cap of Biofil Chem & Pharma?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 21-Nov-2024 16:59 the market cap of Biofil Chem & Pharma stood at ₹97.38.

What is the P/E ratio of Biofil Chem & Pharma?

The latest P/E ratio of Biofil Chem & Pharma as of 21-Nov-2024 16:59 is 153.8.

What is the P/B ratio of Biofil Chem & Pharma?

The latest P/B ratio of Biofil Chem & Pharma as of 21-Nov-2024 16:59 is 5.30.

What is the 52-week high and low of Biofil Chem & Pharma?

The 52-week high of Biofil Chem & Pharma is ₹92.00 and the 52-week low is ₹42.61.

What is the TTM revenue of Biofil Chem & Pharma?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Biofil Chem & Pharma is ₹46.05 ( Cr.) .

About Biofil Chemicals & Pharmaceuticals Ltd

Biofil Chemicals & Pharmaceuticals established in 1985, is part of Cyano Group of Industries. The company is into manufacturing of drugs in area of anti-bacterial, analgesics/antipyretics, anti-malarial, anti-psychotics, anti asthmatic/bronchodilators, diuretics, tranquilizer/hypnotics, anti inflammatory, analgesic/antipyretics, anti inflammatory steroids and eye/ear drops

Its plant is located at Plot No. 8, Sector-IV Kheda Industrial Estate, Pithampur, Dhar District, Madhya Pradesh. The facility has received GMP certificate from Licensing Authority, Food & Drugs Administration, Department of Health and Government of Madhya Pradesh, India.

The manufacturing unit exports around 30 to 40% of their formulation directly or through merchant export to countries in own or neutral labels.

The shares of companies are listed on Bombay Stock Exchange.

Company exports its products to countries namely Kenya, Uganda, Tanzania, Nigeria, U.A.E, Rwanda, Monrovia, Republic of Yemen and Mauritius.